Effect of probiotic strains Lactobacillus acidophilus LAFTI L10 and Lactobacillus paracasei LAFTI L26 on systemic immune functions and bacterial translocation in mice

Journal of Food Protection

Volumn 71, Issue 4, 2008, Pages 796-801

  Paturi, Gunaranjan ^a   Phillips, Michael ^a   Kailasapathy, Kasipathy ^a  

^a UNIVERSITY OF WESTERN SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA (MICROORGANISMS); LACTOBACILLUS; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS PARACASEI; MUS;

EID: 41849084492     PISSN: 0362028X     EISSN: None     Source Type: Journal    
DOI: 10.4315/0362-028X-71.4.796     Document Type: Article

References (43)

1. Arunachalam, K., H. S. Gill, and R. K. Chandra. 2000. Enhancement of natural immune function by dietary consumption of Bifidobacterium lactis (HN019). Eur. J. Clin. Nutr. 54:263-267.
2. Bengmark, S., and B. Jeppsson. 1995. Gastrointestinal surface protection and mucosa reconditioning. J. Parenter. Enteral Nutr. 19:410-415.
3. Berg, R. D. 1992. Translocation of enteric bacteria in health and disease. Curr. Stud. Hematol. Blood Transfus. 59:44-65.
4. Berg, R. D. 1999. Bacterial translocation from the gastrointestinal tract. Adv. Exp. Med. Biol. 473:11-30.
5. Cano, P. G., and G. Perdigon. 2003. Probiotics induce resistance to enteropathogens in a re-nourished mouse model. J. Dairy Res. 70:433-440.
6. Corfield, A. P., D. Carroll, N. Myerscough, and C. S. Probert. 2001. Mucins in the gastrointestinal tract in health and disease. Front. Biosci. 6:D1321-D1357.
7. Daniel, C., S. Poiret, D. Goudercourt, V. Dennin, G. Leyer, and B. Pot. 2006. Selecting lactic acid bacteria for their safety and functionality by use of a mouse colitis model. Appl. Environ. Microbiol. 72:5799-5805.
8. Dunne, C., L. Murphy, S. Flynn, L. O'Mahony, S. O'Halloran, M. Feeney, D. Morrissey, G. Thornton, G. Fitzgerald, C. Daly, B. Kiely, E. M. Quigley, G. C. O'Sullivan, F. Shanahan, and J. K. Collins. 1999. Probiotics: from myth to reality. Demonstration of functionality in animal models of disease and in human clinical trials. Antonie Leeuwenhoek 76:279-292.
9. Gill, H. S., and K. J. Rutherfurd. 2001. Viability and dose-response studies on the effects of the immunoenhancing lactic acid bacterium Lactobacillus rhamnosus in mice. Br. J. Nutr. 86:285-289.
10. Gill, H. S., K. J. Rutherfurd, and M. L. Cross. 2001. Dietary probiotic supplementation enhances natural killer cell activity in the elderly: an investigation of age-related immunological changes. J. Clin. Immunol. 21:264-271.
11. Gill, H. S., K. J. Rutherfurd, J. Prasad, and P. K. Gopal. 2000. Enhancement of natural and acquired immunity by Lactobacillus rhamnosus (HN001), Lactobacillus acidophilus (HN017) and Bifidobacterium lactis (HN019). Br. J. Nutr. 83:167-176.
12. Herias, M. V., C. Hessle, E. Telemo, T. Midtvedt, L. A. Hanson, and A. E. Wold. 1999. Immunomodulatory effects of Lactobacillus plantarum colonizing the intestine of gnotobiotic rats. Clin. Exp. Immunol. 116:283-290.
13. Hessle, C., L. A. Hanson, and A. E. Wold. 1999. Lactobacilli from human gastrointestinal mucosa are strong stimulators of IL-12 production. Clin. Exp. Immunol. 116:276-282.
14. Hosono, A., A. Ozawa, R. Kato, Y. Ohnishi, Y. Nakanishi, T. Kimura, and R. Nakamura. 2003. Dietary fructooligosaccharides induce immunoregulation of intestinal IgA secretion by murine Peyer's patch cells. Biosci. Biotechnol. Biochem. 67:758-764.
15. Kato, I., K. Tanaka, and T. Yokokura. 1999. Lactic acid bacterium potently induces the production of interleukin-12 and IFN-gamma by mouse splenocytes. Int. J. Immunopharmacol. 21:121-131.
16. Kaur, I. P., K. Chopra, and A. Saini. 2002. Probiotics: potential pharmaceutical applications. Eur. J. Pharm. Sci. 15:1-9.
17. Kirjavainen, P. V., H. S. El-Nezami, S. J. Salminen, J. T. Ahokas, and P. F. Wright. 1999. The effect of orally administered viable probiotic and dairy lactobacilli on mouse lymphocyte proliferation. FEMS Immunol. Med. Microbiol. 26:131-135.
18. Leblanc, J., I. Fliss, and C. Matar. 2004. Induction of a humoral immune response following an Escherichia coli O157:H7 infection with an immunomodulatory peptidic fraction derived from Lactobacillus helveticus-fermented milk. Clin. Diagn. Lab. Immunol. 6:1171-1181.
19. Luyer, M. D., W. A. Buurman, M. Hadfoune, G. Speelmans, J. Knol, J. A. Jacobs, C. H. Dejong, A. J. Vriesema, and J. W. Greve. 2005. Strain-specific effects of probiotics on gut barrier integrity following hemorrhagic shock. Infect. Immun. 73:3686-3692.
20. Ma, L., E. Deitch, R. Specian, E. Steffen, and R. Berg. 1990. Translocation of Lactobacillus murinus from the gastrointestinal tract. Curr. Microbiol. 20:177-184.
21. Maassen, C. B., C. van Holten-Neelen, F. Balk, M. J. den Bak-Glashouwer, R. J. Leer, J. D. Laman, W. J. Boersma, and E. Claassen. 2000. Strain-dependent induction of cytokine profiles in the gut by orally administered Lactobacillus strains. Vaccine 18:2613-2623.
22. Marin, M. L., M. V. Tejada-Simon, J. H. Lee, J. Murtha, Z. Ustunol, and J. J. Pestka. 1998. Stimulation of cytokine production in clonal macrophage and T-cell models by Streptococcus thermophilus: comparison with Bifidobacterium sp. and Lactobacillus bulgaricus. J. Food Prot. 61:859-864.
23. Matsuzaki, T. 1998. Immunomodulation by treatment with Lactobacillus casei strain Shirota. Int. J. Food Microbiol. 41:133-140.
24. Medici, M., C. G. Vinderola, R. Weill, and G. Perdigon. 2005. Effect of fermented milk containing probiotic bacteria in the prevention of an enteroinvasive Escherichia coli infection in mice. J. Dairy Res. 72:243-249.
25. Mestecky, J., M. W. Russell, and C. O. Elson. 1999. Intestinal IgA: novel views on its function in the defence of the largest mucosal surface. Gut 44:2-5.
26. Miettinen, M., A. Lehtonen, I. Julkunen, and S. Matikainen. 2000. Lactobacilli and streptococci activate NF-kappa B and STAT signaling pathways in human macrophages. J. Immunol. 164:3733-3740.
27. Miettinen, M., S. Matikainen, J. Vuopio-Varkila, J. Pirhonen, K. Varkila, M. Kurimoto, and I. Julkunen. 1998. Lactobacilli and streptococci induce interleukin-12 (IL-12), IL-18 and gamma interferon production in human peripheral blood mononuclear cells. Infect. Immun. 66:6058-6062.
28. Nader de Macias, M. E., M. C. Apella, N. C. Romero, S. N. Gonzalez, and G. Oliver. 1992. Inhibition of Shigella sonnei by Lactobacillus casei and Lactobacillus acidophilus. J. Appl. Bacteriol. 73:407-411.
29. Paturi, G., M. Phillips, M. Jones, and K. Kailasapathy. 2007. Immune enhancing effects of Lactobacillus acidophilus LAFTI L10 and Lactobacillus paracasei LAFTI L26 in mice. Int. J. Food Microbiol. 115:115-118.
30. Perdigon, G., and S. Alvarez. 1992. Probiotics and immune state, p. 146-180. In R. Fuller (ed.), Probiotics: the scientific basis. Chapman and Hall, London.
31. Perdigon, G., M. E. de Macias, S. Alvarez, G. Oliver, and A. A. de Ruiz Holgado. 1986. Effect of perorally administered lactobacilli on macrophage activation in mice. Infect. Immun. 53:404-410.
32. Perdigon, G., C. Maldonado Galdeano, J. C. Valdez, and M. Medici. 2002. Interaction of lactic acid bacteria with the gut immune system. Eur. J. Clin. Nutr. 56:S21-S26.
33. Perdigon, G., M. Rachid, M. V. De Budeguer, and J. C. Valdez. 1994. Effect of yogurt feeding on the small and large intestine associated lymphoid cells in mice. J. Dairy Res. 61:553-562.
34. Perdigon, G., E. Vintini, S. Alvarez, M. Medina, and M. Medici. 1999. Study of the possible mechanisms involved in the mucosal immune system activation by lactic acid bacteria. J. Dairy Sci. 82:1108-1114.
35. Roller, M., A. Pietro Femia, G. Caderni, G. Rechkemmer, and B. Watzl. 2004. Intestinal immunity of rats with colon cancer is modulated by oligofructose-enriched inulin combined with Lactobacillus rhamnosus and Bifidobacterium lactis. Br. J. Nutr. 92:931-938.
36. Sato, K., H. Saito, H. Tomioka, and T. Yokokura. 1998. Enhancement of host resistance against Listeria infection by Lactobacillus casei: efficacy of cell wall preparation of Lactobacillus casei. Microbiol. Immunol. 32:1189-1200.
37. Schiffrin, E. J., D. Brassart, A. L. Servin, F. Rochat, and A. Donnet-Hughes. 1997. Immune modulation of blood leukocytes in humans by lactic acid bacteria: criteria for strain selection. Am. J. Clin. Nutr. 66:515S-520S.
38. Schultz, M., H. J. Linde, N. Lehn, K. Zimmermann, J. Grossmann, W. Falk, and J. Scholmerich. 2003. Immunomodulatory consequences of oral administration of Lactobacillus rhamnosus strain GG in healthy volunteers. J. Dairy Res. 70:165-173.
39. Tejada-Simon, M. V., Z. Ustunol, and J. J. Pestka. 1999. Ex vivo effects of lactobacilli, streptococci, and bifidobacteria ingestion on cytokine and nitric oxide production in a murine model. J. Food Prot. 62:162-169.
40. Vinderola, C. G., M. Medici, and G. Perdigon. 2004. Relationship between interaction sites in the gut: Hydrophobicity, mucosal immunomodulating capacities and cell wall protein profiles in indigenous and exogenous bacteria. J. Appl. Microbiol. 96:230-243.
41. Wagner, R. D., T. Warner, L. Roberts, J. Farmer, and E. Balish. 1997. Colonization of congenitally immunodeficient mice with probiotic bacteria. Infect. Immun. 65:3345-3351.
42. Wells, C. L., M. A. Maddaus, and R. L. Simmons. 1998. Proposed mechanisms for the translocation of intestinal bacteria. Rev. Infect. Dis. 10:958-979.
43. Zareie, M., K. Johnson-Henry, J. Jury, P. C. Yang, B. Y. Ngan, D. M. McKay, J. D. Soderholm, M. H. Perdue, and P. M. Sherman. 2006. Probiotics prevent bacterial translocation and improve intestinal barrier function in rats following chronic psychological stress. Gut 55:1553-1560.